NCT02879331

Brief Summary

The study hypothesis is that patients with homogeneous emphysema behave differently compared to heterogeneous emphysema with respect to exercise capacity. A better understanding of this difference will allow the investigators to choose the best treatment for each type of patient. The main purpose of this study is to evaluate the change in exercise capacity measured by cycle ergometry in patients with severe emphysema after endoscopic lung volume reduction with coils (eLVR). As a secondary purpose, the investigators want to perform an exploratory, randomized study to compare the results of two different therapeutic approaches in a small sample of patients with homogeneous emphysema.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2016

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 25, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

March 1, 2019

Status Verified

February 1, 2019

Enrollment Period

4.8 years

First QC Date

July 29, 2016

Last Update Submit

February 28, 2019

Conditions

Keywords

pulmonary emphysemacoilscycloergometrylung volume reduction

Outcome Measures

Primary Outcomes (1)

  • Change in Inspiratory Capacity (L)

    Change in Inspiratory Capacity (L) at 6 months from baseline

    three months before procedure and six months after first procedure

Secondary Outcomes (7)

  • RV (L)

    three months before procedure and six months after first procedure

  • 6-MWT (m)

    three months before procedure and six months after first procedure

  • SGQLT (measured in points)

    three months before procedure and six months after first procedure

  • FEV1(measured in liters)

    three months before procedure and six months after first procedure

  • FVC (measured in liters)

    three months before procedure and six months after first procedure

  • +2 more secondary outcomes

Study Arms (2)

10 coils in upper lobes

ACTIVE COMPARATOR

10 coils in upper lobes

Procedure: 10 coils in upper lobesProcedure: cycloergometry

15 coils in upper and lower lobes

EXPERIMENTAL

15 coils in upper and lower lobes

Procedure: 15 coils in upper and lower lobesProcedure: cycloergometry

Interventions

10 coils in upper lobes
15 coils in upper and lower lobes
10 coils in upper lobes15 coils in upper and lower lobes

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Emphysematous patient
  • FEV1 \< 50%
  • RV \> 200%
  • Diffusion \<60% \>20%
  • PSP \<55 mmHg

You may not qualify if:

  • Anticoagulants/antiplatelets
  • Giant bullae (\> 8 cm , 1/3 hemithorax)
  • More tan three moderate/severe exacerbation per year
  • Negative to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fundación Jiménez Díaz

Madrid, 28040, Spain

RECRUITING

Related Publications (4)

  • Hartman JE, Klooster K, Ten Hacken NH, Slebos DJ. Treatment of emphysema using bronchoscopic lung volume reduction coil technology: an update on efficacy and safety. Ther Adv Respir Dis. 2015 Oct;9(5):251-9. doi: 10.1177/1753465815589904. Epub 2015 Jun 25.

    PMID: 26113524BACKGROUND
  • Deslee G, Klooster K, Hetzel M, Stanzel F, Kessler R, Marquette CH, Witt C, Blaas S, Gesierich W, Herth FJ, Hetzel J, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014 Nov;69(11):980-6. doi: 10.1136/thoraxjnl-2014-205221. Epub 2014 Jun 2.

    PMID: 24891327BACKGROUND
  • Boutou AK, Zoumot Z, Nair A, Davey C, Hansell DM, Jamurtas A, Polkey MI, Hopkinson NS. The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction. COPD. 2015;12(6):598-605. doi: 10.3109/15412555.2015.1020149. Epub 2015 Sep 23.

    PMID: 26398112BACKGROUND
  • Aros F, Boraita A, Alegria E, Alonso AM, Bardaji A, Lamiel R, Luengo E, Rabadan M, Alijarde M, Aznar J, Bano A, Cabanero M, Calderon C, Camprubi M, Candell J, Crespo M, de la Morena G, Fernandez A, Ferrero JA, Gayan R, Bolao IG, Hernandez M, Maceira A, Marin E, Muela de Lara A, Placer L, San Roman JA, Serratosa L, Sosa V, Subirana MT, Wilke M. [Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing]. Rev Esp Cardiol. 2000 Aug;53(8):1063-94. Spanish.

    PMID: 10956604BACKGROUND

MeSH Terms

Conditions

Pulmonary Emphysema

Condition Hierarchy (Ancestors)

Pulmonary Disease, Chronic ObstructiveLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Iker Fernandez-Navamuel, MD, PhD

    FJD

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lucia Llanos, MD, PhD

CONTACT

Javier Flandes, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2016

First Posted

August 25, 2016

Study Start

November 1, 2016

Primary Completion

September 1, 2021

Study Completion

December 1, 2021

Last Updated

March 1, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations